Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 623-629

  Hirata, Ayumu ^a   Kishida, Ken ^a   Hiuge Shimizu, Aki ^a   Nakatsuji, Hideaki ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Qualitative ultrasonography; Systemic arteriosclerosis

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ABDOMINAL AORTA; ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CLINICAL ASSESSMENT TOOL; CORONARY ARTERY DISEASE; DIABETIC MICROANGIOPATHY; DIAGNOSTIC VALUE; DISEASE DURATION; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; ILIAC ARTERY; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RENAL ARTERY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMIC ARTERIOSCLEROSIS; SYSTEMIC VASCULAR SCORE; TOE BRACHIAL INDEX; VASCULAR ECHOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ILIAC ARTERY; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL ARTERY; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 82955176944     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.043     Document Type: Article

References (37)

1. Roper N.A., Bilous R.W., Kelly W.F., Unwin N.C., Connolly V.M. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001, 322:1389-1393.
2. Steg P.G., Bhatt D.L., Wilson P.W., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007, 297:1197-1206.
3. Nakamura S., Iihara K., Matayoshi T., et al. The incidence and risk factors of renal artery stenosis in patients with severe carotid artery stenosis. Hypertens Res 2007, 30:839-844.
4. Wackers F.J., Young L.H., Inzucchi S.E., et al. Detection of Ischemia in Asymptomatic Diabetics Investigators Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004, 27:1954-1961.
5. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
6. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999, 340:14-22.
7. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467. [review].
8. Katakami N., Matsuhisa M., Kaneto H., et al. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Atherosclerosis 2009, 204:288-292.
9. Terminology Diagnostic Criteria Committee, Japan Society of Ultrasonics in Medicine Subcommittee for preparing guidelines for ultrasound diagnosis of carotid artery: standard method for ultrasound evaluation of carotid artery lesions. Jpn J Med Ultrasonics 2009, 36:501-518.
10. Machino-Ohtsuka T., Seo Y., Ishizu T., et al. Combined assessment of carotid vulnerable plaque, renal insufficiency, eosinophilia, and hs-CRP for predicting risky aortic plaque of cholesterol crystal embolism. Circ J 2010, 74:51-58.
11. Zeller T., Bonvini R.F., Sixt S. Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization. Catheter Cardiovasc Interv 2008, 71:995-999.
12. Alcorn H.G., Wolfson S.K., Sutton-Tyrrell K., Kuller L.H., O'Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996, 16:963-970.
13. Upton M.T., Rerych S.K., Newman G.E., Port S., Cobb F.R., Jones R.H. Detecting abnormalities in left ventricular function during exercise before angina and ST-segment depression. Circulation 1980, 62:341-349.
14. Aronow W.S., Cassidy J. Five year follow-up of double Master's test, maximal treadmill stress test, and resting and postexercise apexcardiogram in asymptomatic persons. Circulation 1975, 52:616-618.
15. Inobe Y., Kugiyama K., Morita E., et al. Role of adenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurements and thallium-201 myocardial single-photon emission computed tomography. J Am Coll Cardiol 1996, 28:890-896.
16. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975, 51:5-40.
17. Ryo M., Maeda K., Onda T., et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care 2005, 28:451-453.
18. Matsuo S., Imai E., Horio M., et al. Collaborators developing the Japanese equation for estimated GFR revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
19. Teramoto T., Sasaki J., Ueshima H., et al. Metabolic syndrome. J Atheroscler Thromb 2008, 15:1-5. [review].
20. Okauchi Y., Kishida K., Funahashi T., et al. Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. J Atheroscler Thromb 2010, 17:1237-1245.
21. Bhatt D.L., Steg P.G., Ohman E.M., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295:180-189.
22. Valensi P., Pariès J., Brulport-Cerisier V., et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care 2005, 28:2722-2727.
23. American Diabetes Association Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 1998, 21:1551-1559.
24. Gianrossi R., Detrano R., Mulvihill D., et al. Exercise induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989, 80:87-98. [review].
25. Nishimura S., Mahmarian J.J., Boyce T.M., Verani MS Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease. J Am Coll Cardiol 1991, 18:736-745.
26. Hunink M.G., Gazelle G.S. CT screening: a trade-off of risks, benefits, and costs. J Clin Invest 2003, 111:1612-1619. [review].
27. Le Feuvre C., Jacqueminet S., Barthelemy O. Myocardial ischemia: a silent epidemic in Type 2 diabetes patients. Future Cardiol 2011, 7:183-190.
28. Kuo P.H., Kanal E., Abu-Alfa A.K., Cowper S.E. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007, 242:647-649.
29. Kablak-Ziembicka A., Przewlocki T., Tracz W., et al. Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis. Atherosclerosis 2007, 193:395-400.
30. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 28:1462-1536.
31. Graham I., Atar D., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prev Rehabil 2007, 14:E1-E40.
32. Helfand M., Buckley D.I., Freeman M., et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 151:496-507. [review].
33. Costanzo P., Perrone-Filardi P., Vassallo E., et al. Does carotid intima-media thickness regression predict reduction of cardiovascular events?. A meta-analysis of 41 randomized trials. J Am Coll Cardiol 2010, 56:2006-2020.
34. Otah K.E., Madan A., Otah E., Badero O., Clark L.T., Salifu M.O. Usefulness of an abnormal ankle-brachial index to predict presence of coronary artery disease in African-Americans. Am J Cardiol 2004, 93:481-483.
35. Hayashi C., Ogawa O., Kubo S., Mitsuhashi N., Onuma T., Kawamori R. Ankle brachial pressure index and carotid intima-media thickness as atherosclerosis markers in Japanese diabetics. Diabetes Res Clin Pract 2004, 66:269-275.
36. Doobay A.V., Anand S.S. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 2005, 25:1463-1469. [review].
37. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.